3-98391215-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005516.1(OR5K3):āc.550T>Gā(p.Leu184Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,612,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005516.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5K3 | NM_001005516.1 | c.550T>G | p.Leu184Val | missense_variant | 1/1 | ENST00000383695.1 | NP_001005516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5K3 | ENST00000383695.1 | c.550T>G | p.Leu184Val | missense_variant | 1/1 | 6 | NM_001005516.1 | ENSP00000373194.1 | ||
ENSG00000251088 | ENST00000508616.1 | n.188+48786T>G | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250532Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135502
GnomAD4 exome AF: 0.0000685 AC: 100AN: 1460182Hom.: 0 Cov.: 31 AF XY: 0.0000702 AC XY: 51AN XY: 726528
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.550T>G (p.L184V) alteration is located in exon 1 (coding exon 1) of the OR5K3 gene. This alteration results from a T to G substitution at nucleotide position 550, causing the leucine (L) at amino acid position 184 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at